Abstract Background and Aims The COVID‐19 pandemic has presented significant challenges to clinical research, necessitating the adoption of innovative and remote …
The world is in the midst of a pandemic. We still know little about the disease COVID-19 or about the virus (SARS-CoV-2) that causes it. We do not have a vaccine or a treatment (aside …
CU Kunz, S Jörgens, F Bretz, N Stallard… - Statistics in …, 2020 - Taylor & Francis
Very recently the new pathogen severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) was identified and the coronavirus disease 2019 (COVID-19) declared a pandemic …
COVID-19 is having substantial impacts on research conduct, including clinical trials. However, there is limited research investigating the impact of the pandemic on the conduct …
The COVID-19 pandemic continues to affect the conduct of clinical trials globally. Complications may arise from pandemic-related operational challenges such as site …
AH Talal, M Markatou, EM Sofikitou, LS Brown… - Contemporary Clinical …, 2022 - Elsevier
Background Telemedicine has the potential to increase healthcare access especially for vulnerable populations. Telemedicine for Evaluation, Adherence, and Medication for …
ON Keene, D Wright, A Phillips, M Wright - Contemporary Clinical Trials, 2021 - Elsevier
For many years there has been a consensus among the Clinical Research community that ITT analysis represents the correct approach for the vast majority of trials. Recent worldwide …
X Wang, P Yang, SS Yuan… - Journal of …, 2023 - Taylor & Francis
Defining the right question of interest is important to a clinical study. ICH E9 (R1) introduces the framework of an estimand and its five attributes, which provide a basis for connecting …
JC Reid, A Molloy, G Strong, L Kelly, H O'Grady… - Trials, 2022 - Springer
Rationale The COVID-19 pandemic disrupted non-COVID critical care trials globally as intensive care units (ICUs) prioritized patient care and COVID-specific research. The …